A5038469257- Colorectal Cancer Treatments and Studies
- Sexual function and dysfunction studies
- Esophageal Cancer Research and Treatment
- Gastric Cancer Management and Outcomes
- Menopause: Health Impacts and Treatments
- Genetic factors in colorectal cancer
- Gestational Trophoblastic Disease Studies
- Colorectal Cancer Screening and Detection
- Pelvic floor disorders treatments
- Theoretical and Computational Physics
- Complex Systems and Time Series Analysis
- Complex Network Analysis Techniques
Catholic University of the Maule
2021-2023
Hospital Regional de Talca
2013
Hospital Barros Luco-Trudeau
2003
In order to determine the prevalence of sexual dysfunction (SD) and related risk factors in a cohort middle-aged women Laumann's test (DSM-IV) was passed 534 healthy between 40 64 years old (mean: 52.4+/-5.7) attending Southern Metropolitan Health Service Santiago de Chile. Of all women, 82.8% were peri- or postmenopausal, 23% had received hormone replacement therapy (HRT) 79.2% sexually active. Among those who active total 51.3% presented SD. The SD increased with age (from 22.2% 40-44-year...
411 Background: LEAP-015 (NCT04662710) is a randomized, open-label, 2-part, phase 3 study of the safety and efficacy lenvatinib + pembrolizumab chemotherapy as first-line treatment for advanced/metastatic gastroesophageal adenocarcinoma. We report findings from part 1, run-in, LEAP-015. Methods: Eligible patients had untreated, HER2-negative, locally advanced unresectable or metastatic adenocarcinoma, measurable disease per RECIST v1.1, ECOG performance status 0 1. In received induction with...